发明公开
- 专利标题： NAPHTHALENE DERIVATIVE
- 专利标题（中）： NAPHTHALINDERIVAT
-
申请号： EP11812583.0申请日： 2011-07-28
-
公开(公告)号： EP2599771A1公开(公告)日： 2013-06-05
- 发明人: KAKIZUKA, Akira , HORI, Seiji , SHUDO, Toshiyuki , FUCHIGAMI, Tomohiro
- 申请人： Daito Chemix Corporation , Kyoto University
- 申请人地址： 1-7, Matta Ohmiya 3-chome Tsurumi-ku Osaka-shi, Osaka, 538-0031 JP
- 专利权人： Daito Chemix Corporation,Kyoto University
- 当前专利权人： Daito Chemix Corporation,Kyoto University
- 当前专利权人地址： 1-7, Matta Ohmiya 3-chome Tsurumi-ku Osaka-shi, Osaka, 538-0031 JP
- 代理机构： HOFFMANN EITLE
- 优先权： JP2010172467 20100730
- 国际公布： WO2012014994 20120202
- 主分类号： C07C309/47
- IPC分类号： C07C309/47 ; A61K31/655 ; A61P1/00 ; A61P1/04 ; A61P1/08 ; A61P1/18 ; A61P3/06 ; A61P9/10 ; A61P9/12 ; A61P11/00 ; A61P13/02 ; A61P13/08 ; A61P13/12 ; A61P17/00 ; A61P19/00 ; A61P19/02 ; A61P19/10 ; A61P21/00 ; A61P25/00 ; A61P25/06
摘要：
The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I)
(R is as defined in the description)
or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.
(R is as defined in the description)
or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.
公开/授权文献
- EP2599771B1 NAPHTHALENE DERIVATIVE 公开/授权日：2016-09-14
信息查询
